STOCK TITAN

HCM IV Acquisition Corp. Unit 8-K Filings

HACQU NASDAQ

Every 8-K that HCM IV Acquisition Corp. Unit (HACQU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow HACQU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HACQU filings page.

Rhea-AI Summary

HCM IV Acquisition Corp. reported that, starting on April 6, 2026, investors who hold its Nasdaq-traded units (symbol “HACQU”) from the initial public offering may choose to trade the underlying Class A ordinary shares and warrants separately.

Each unit consists of one Class A ordinary share and one-quarter of one redeemable warrant, with each whole warrant exercisable to buy one Class A ordinary share at $11.50 per share. After separation, the Class A ordinary shares are expected to trade under “HACQ” and the warrants under “HACQW,” while any units that are not separated will continue trading under “HACQU.” No fractional warrants will be issued, and only whole warrants will trade.

Rhea-AI Summary

HCM IV Acquisition Corp. completed its initial public offering of 28,750,000 units at $10.00 per unit, including full exercise of the over‑allotment, for $287,500,000 of gross proceeds placed in a U.S. trust account. Each unit includes one Class A ordinary share and one‑quarter of a redeemable warrant exercisable at $11.50 per share. The SPAC is a blank check company with no operating business and has not selected or begun substantive talks with any acquisition target. Audited balance sheet data show Class A shares are fully redeemable at $10.00 per share, while the sponsor holds 8,625,000 Class B founder shares and 3,833,333 private placement warrants. The auditor’s report highlights substantial doubt about the company’s ability to continue as a going concern because it lacks sufficient cash and working capital outside the trust and must complete a business combination within 24 months or liquidate.

Rhea-AI Summary

HCM IV Acquisition Corp., a blank check company, has completed its initial public offering of 28,750,000 units, including the full 3,750,000-unit over-allotment, at $10.00 per unit, for $287,500,000 in gross proceeds. Each unit includes one Class A ordinary share and one-third or one-fourth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share.

The company also sold 4,666,667 private placement warrants to its sponsor and the underwriter at $1.50 per warrant, generating an additional $7,000,000. A total of $287,500,000, including $13,687,500 of deferred underwriting discount, has been placed in a U.S.-based trust account. These funds will remain in trust until a business combination is completed or the 24‑month deadline passes, when public shares may be redeemed.

The company’s amended and restated memorandum and articles of association were approved in connection with the IPO. HCM IV Acquisition Corp. plans to target businesses providing disruptive technology or innovations within the financial services industry.